Wikisage, the free encyclopedia of the second generation, is digital heritage


From Wikisage
Revision as of 21:53, 26 February 2019 by Penarc (talk | contribs) (ATC)
Jump to navigation Jump to search

Diacomit ®contains 250 mg stiripentol[1][2]


In December 2001 the European Medicines Agency (EMA) granted stiripentol orphan drug status (designation number EU/3/01/071) for the treatment of severe myoclonic epilepsy of infancy (Dravet's syndrome). On 4 January 2007, the EMA granted the drug a marketing authorisation that is valid throughout the European Union Dravet's syndrome does not exist data for combined therapy both valproic acid or clobazam[4]